Skip to content

Utah Medical Products UTMD Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount

Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount at other companies

Baxter International logo
Baxter InternationalBAX
$4.5M-5.3%
Avanos Medical logo
Avanos MedicalAVNS
$375K

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxCreditsResearch.

The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's effective income tax rate reconciliation, tax credit, research, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's effective income tax rate reconciliation, tax credit, research, amount?
Utah Medical Products (UTMD) reported effective income tax rate reconciliation, tax credit, research, amount of $3.75K in Q4 2025.
How has Utah Medical Products's effective income tax rate reconciliation, tax credit, research, amount changed year-over-year?
Utah Medical Products's effective income tax rate reconciliation, tax credit, research, amount decreased by 79.2% year-over-year, from $18K to $3.75K.
What is the long-term trend for Utah Medical Products's effective income tax rate reconciliation, tax credit, research, amount?
Over 2 years (2021 to 2025), Utah Medical Products's effective income tax rate reconciliation, tax credit, research, amount has grown at a 58.1% compound annual growth rate (CAGR), from $6K to $15K.
What does effective income tax rate reconciliation, tax credit, research, amount mean?
This metric quantifies the reduction in income tax expense resulting from research and development tax credits. It highlights the company's ability to leverage government incentives to lower its overall tax liability through innovation investment.